Putative role of calpain in the pathophysiology of experimental optic neuritis

Experimental Eye Research

Volumn 67, Issue 4, 1998, Pages 403-410

  Shields, Donald C ^a   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Calpain; Calpastatin; Experimental allergic encephalomyelitis; Multiple sclerosis; Optic neuritis; Transcriptional expression; Translational expression

Indexed keywords

CALPAIN; CALPASTATIN; MYELIN ASSOCIATED GLYCOPROTEIN;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; EXPERIMENTAL MODEL; GENE EXPRESSION; MALE; MULTIPLE SCLEROSIS; NONHUMAN; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

EID: 0032192542     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1998.0537     Document Type: Article

References (68)

1. Azuma M., Inoue E., Oka T., Shearer T. R. Proteolysis by calpain is an underlying mechanism for formation of sugar cataract in rat lens. Curr. Eye Res. 14:1995;27-34.
2. Banay-Schwartz M., Deguzman T., Palkovits M., Lajtha A. Calpain activity in adult and aged human brain regions. Neurochem. Res. 19:1994;563-567.
3. Banik N. L. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Crit. Rev. Neurobiol. 16:1992;257-271.
4. Banik N. L, Chakrabarti A. K., Hogan E. L. Calcium-activated neural proteinase in myelin: Its role and function. Myelin, Biology and Chemistry. 1992;CRC Press. p. 571-98.
5. 2+. J. Neurochem. 45:1985;581-588.
6. Banik N. L., Chakrabarti A. K., Hogan E. L. Purification of an endogenous 68 kD inhibitor of calcium-activated neutral proteinase (CANP) from bovine brain: Immunoblot identification and characterization. J. Neurosci. Res. 25:1990;119-124.
7. Banik N. L., Matzelle D. C., Gantt-Wilford G., Osborne A., Hogan E. L. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752:1997a;301-306.
8. Banik N. L., Lobo D., Terry E., Hogan E. L. A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation. Brain Res. 748:1997b;205-210.
9. Banik N. L., Shields D. C., Ray S., Davis B., Matzelle D., Wilford G., Hogan E. L. Role of calpain in spinal cord injury: effects of calpain and free radical inhibitors. Ann. NY Acad. Sci. 844:1998;131-137.
10. Bartus R., Heyward N. J., Elliott P. J., Sawyer S. D., Dean R. L., Akiyuama A., Straub J. A., Harbeson S. L., Li Z. Calpain inhibitor AK295 protects neurons from focal brain ischemia; effects of post-occlusion intra-arterial administration. Stroke. 25:1995;2265-2270.
11. Blomgren K., Karlsson J. Calpain and calpastatin activity in the optic pathway. Neurosci. Lett. 112:1990;179-183.
12. Bullington S. J., Waksman B. H. Uveitis in rabbits with experimental allergic encephalomyelitis. Arch. Ophthalmol. 59:1958;435-445.
13. Chakrabarti A. K., Yoshida Y., Powers J. M., Singh I., Hogan E. L., Banik N. L. Calcium-activated neutral proteinases in rat brain and subcellular fractions. J. Neurosci. Res. 20:1988;351-358.
14. Chakrabarti, A. K., Banik, N. L., Lobo, D. and Terry, E. (1990). Calcium-activated neutral proteinase in neural cells (Abstr.) Trans. Amer. Soc. Neurochem. 21, 259.
15. Compston A. Cellular organization of the optic nerve and the implications for optic neuritis. Eye. 6:1992;123-128.
16. David L. L., Shearer T. R. Purification of calpain II from rat lens and determination of endogenous substrates. Exp. Eye Res. 42:1986;227-238.
17. 2+. Biochemistry. 15:1976;2159-2167.
18. Deshpande R. V., Goust J. M., Hogan E. L., Banik N. L. Calpain secreted by activated human lymphoid cells degrades myelin. J. Neurosci. Res. 42:1995;259-265.
19. De Tullio R., Sparatore B., Salamino F., Melloni E., Pontremoli S. Rat brain contains multiple mRNAs for calpastatin. FEBS Lett. 422:1998;113-117.
20. Einstein E. R., Csejtey J., Dalal K. B., Adams C. W. M., Bayliss O., Hallpike J. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations. J. Neurochem. 19:1972;653-662.
21. George E. B., Glass J. D., Griffin J. W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15:1995;6445-6452.
22. Hallpike J. B., Adams C. W. M. Proteolysis of myelin breakdown: a review of recent histochemical and biochemical studies. Histochem. J. 1:1969;559-578.
23. Hata A., Ohno S., Akita Y., Suzuki K. Tandemly reiterated negative enhancer-like elements regulate transcription of a human gene for the large subunit of calcium-dependent protease. J. Biol. Chem. 264:1989;6404-6411.
24. Hogan E. L, Banik N. L, Goust J. M., Lobo D. Enzymes in cerebrospinal fluid: evidence for a calcium-activated neutral proteinase in CSF. Lowenthal A., Raus J. Cellular and humoral components of cerebrospinal fluid in multiple sclerosis. 1987;479-488 Elsevier, Amsterdam.
25. Inomata M., Nomoto M., Hayashi M., Nakamura M., Imahori K., Kawashima S. Comparison of low and high calcium requiring forms of the calcium-activated neutral protease (CANP) from rabbit skeletal muscle. J. Biochem. 95:1984;1661-1670.
26. James T., Matzelle D., Bartus R., Hogan E. L., Banik N. L. New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J. Neurosci. Res. 51:1998;218-222.
27. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of Bacteriophage T. Nature. 227:1970;680-685.
28. Lee W. J., Ma H., Takano E., Yang H. Q., Hatanaka M., Maki M. Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J. Biol. Chem. 267:1992;8437-8442.
29. Linnington C., Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/ oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 17:1987;61-69.
30. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
31. McCarthy J. E. G., Kollmus H. Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. Trends Biochem. Sci. 20:1995;191-197.
32. Mellgren R. L. Calcium-dependent proteases: an enzyme system active at cellular membranes. FASEB J. 1:1987;110-115.
33. Moller J. R. Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates. Brain Res. 741:1996;27-31.
34. 2+. J. Biol. Chem. 257:1982;5544-5553.
35. Newcombe J., Glynn P., Cuzner M. L. The immunological identification of brain proteins on cellulose nitrate in human demyelinating disease. J. Neurochem. 38:1982;267-274.
36. Nixon R. A. Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activated in neurons. J. Neurosci. 6:1986;1264-1271.
37. Ozawa K., Saida T., Saida K., Nishitani H., Kameyama M. In vivo CNS demyelination mediated by anti-galactocerobroside antibody. Acta Neuropathol. (Berl). 77:1989;621-628.
38. Posmantur R., Hayes R. L., Dixon C. E., Taft W. C. Neurofilament 68 and Neurofilament 200 Protein Levels After Traumatic Brain Injury. J. Neurotrauma. 11:1994;533-545.
39. Raine C. S., Traugott U., Nussenblatt R. B., Stone S. H. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis. Laboratory Investigation. 42:1980;327-335.
40. Rao N. A. Chronic experimental allergic encephalomyelitis. Invest. Ophthalmol. Vis. Sci. 20:1981;159-172.
41. Rao N. A., Guy J., Sheffield P. S. Effects of chronic demyelination on axonal transport in experimental allergic optic neuritis. Invest. Ophthalmol. Vis. Sci. 21:1981;606-611.
42. Saido T. C., Yokota M., Nagao S., Yamaura I., Tani E., Tsuchiya T., Suzuki K., Kawashima S. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268:1993;25239-25243.
43. Sato S., Yanagisawa K., Miyatake T. Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP) - like enzyme in myelin and inhibition by E-64 analogue. Neurochem. Res. 9:1984a;629-635.
44. Sato S., Quarles R. H., Brady R. O., Tourtellotte W. W. Elevated neutral proteinase activity in myelin from multiple sclerosis brain. Ann. Neurol. 15:1984b;264-267.
45. Schlaepfer W. W. Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophore. Nature. 265:1977;734-736.
46. Schlaepfer W. W., Zimmerman U. J. P. The degradation of neurofilaments by calpains. Mellgren R. L., Murachi T. Intracellular calcium-dependent proteolysis. 1990;241-250 CRC Press.
47. Scolding N. J., Jones J., Compston D. A., Morgan B. P. Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology. 70:1990;6-10.
48. Shearer T. R., David L. L. Calpains in Lens and Cataract. Mellgren R. L., Murachi T. Intracellular calcium-dependent proteolysis. 1990;265-276 CRC Press.
49. Shields D. C., Banik N. L. Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: a putative role for calpain in demyelination. Brain Res. 794 (1):1998;68-74.
50. Shields, D. C., Deibler, G. E. and Banik, N. L. (1997a). Increased calpain expression in EAE (abstr.) J. Neurochem. 69, S226.
51. Shields D. C., LeBlanc C., Banik N. L. Calcium-mediated neurofilament protein degradation in rat optic nerve in vitro: activity and autolysis of calpain proenzyme. Exp. Eye Res. 65:1997b;15-21.
52. Shields D. C., Tyor W. R., Deibler G. E., Banik N. L. Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study. Brain Res. 784:1998;299-304.
53. Silberberg D. H., Manning M. C., Schreiber A. D. Tissue culture demyelination by normal human serum. Ann. Neurol. 15:1984;575-580.
54. Siman R., Gall C., Perlmutter L. S., Christian C., Baudry M., Lynch G. Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain. Brain Res. 347:1985;399-403.
55. Smith M. E. Neutral protease activity in lymphocytes of Lewis rats with acute experimental allergic encephalomyelitis. Neurochem Res. 4:1979;689-702.
56. Springer J. E., Azbill R. D., Kennedy S. E., George J., Geddes J. W. Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J. Neurochem. 69:1997;1592-1600.
57. Standart N., Jackson R. J. Regulation of translation by specific protein/mRNA interactions. Biochimie. 76:1994;867-879.
58. 2+2+. J. Biochem. 90:1981;275-278.
59. Suzuki K., Imajoh S., Emori Y., Kawasaki H., Minami Y., Ohno S. Calcium-activated neutral protease and its endogenous inhibitor. FEBS Lett. 220:1987;271-277.
60. Suzuki K., Sorimachi H., Yoshizawa T., Kinbara K., Ishiura S. Calpain: novel family members, activation, and physiological function. Biol. Chem. 376:1995;523-529.
61. Takahashi K. Calpain substrate specificity. Mellgren R. L., Murachi T. Intracellular calcium-dependent proteolysis. 1990;55-74 CRC Press.
62. Towbin H., Stachlin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
63. Tsubata T., Takashashi K. Limited proteolysis of bovine myelin basic protein by calcium-dependent proteinase from bovine spinal cord. J. Biochem. 105:1989;23-28.
64. 2+2+. Exp. Eye Res. 41:1985;97-103.
65. Waxman S. G. Demyelinating diseases - new pathological insights, new therapeutic targets. New Eng. J. Med. 338:1998;323-325.
66. Yanagisawa K., Sato S., O'Shannessy D. J., Quarles R. H., Suzuki K., Miyatake T. Myelin-associated calpain II. J. Neurochem. 51:1988;803-807.
67. Yano T., Kobayashi A., Kurata S., Natori S. Purification and characterization of cathepsin B mRNA 3"-untranslated-region-binding protein (CBBP), a protein that represses cathepsin B mRNA translation. Eur. J. Biochem. 245:1997;260-265.
68. Zajicek J. P., Wing M., Scolding N. J., Compston D. A. Interactions between oligodendrocytes and microglia. A major role for complement and tumor necrosis factor in oligodendrocyte adherence and killing. Brain. 115:1992;1611-1631.